Figure 1From: Incidence and risk factors of severe adverse events with nevirapine-based antiretroviral therapy in HIV-infected women. MTCT-Plus program, Abidjan, Côte d'Ivoire Probability of occurrence of severe adverse events (grade ¾) and/or death in women initiating a nevirapine-based antiretroviral therapy in the MTCT-Plus program in Abidjan, Côte d'Ivoire Back to article page